Computational analyses and prediction of guanylin deleterious SNPs

William F Porto1, Octávio L Franco2, Sérgio A Alencar3

  • 1Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília-DF, Brazil; Centro de Análises Proteômicas e Bioquímicas, Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília-DF, Brazil.

Peptides
|April 23, 2015
PubMed

Insights

Single nucleotide polymorphisms (SNPs) in the human guanylin (GUCA2A) gene can alter protein structure and function. This study identifies specific deleterious missense and nonsense SNPs, aiding in genetic disease association studies.

Area of Science:

  • Genetics
  • Molecular Biology
  • Biochemistry

Background:

  • Human guanylin (GUCA2A) regulates electrolyte and water transport.
  • Guanylin peptide deregulation is linked to colon cancer and intestinal polyps.
  • Mutations in guanylin receptors are implicated in meconium ileus.

Purpose of the Study:

  • To investigate the structural and functional impact of single nucleotide polymorphisms (SNPs) in the GUCA2A gene.
  • To identify deleterious missense and nonsense SNPs in guanylin peptides using in silico methods.

Main Methods:

  • Comprehensive in silico analysis of missense SNPs in the GUCA2A gene using 16 prediction tools.
  • Molecular dynamics simulations (50 ns) to evaluate the structural effects of selected deleterious variants.
  • Identification of nonsense SNPs and their predicted impact on protein synthesis.

Main Results:

  • Three missense variants (Cys104Arg, Cys112Ser, Cys115Tyr) showed significant structural modifications (flexibility, volume, solvation) in molecular dynamics simulations.
  • Two nonsense SNPs were identified, predicted to cause truncated proteins and prevent disulfide bond formation.
  • The study successfully filtered potentially deleterious SNPs for further in vitro evaluation.

Conclusions:

  • In silico structural analysis of missense SNPs is crucial for prioritizing mutations for experimental validation.
  • Identified GUCA2A SNPs provide insights into structural and functional aspects of guanylin peptides.
  • This research contributes to understanding the genetic basis of diseases associated with guanylin peptide dysregulation.